Abstract | BACKGROUND: METHODS: From January 2020 to December 2021, Primipara who planned to undergo second-trimester induced labor in the First Affiliated Hospital of Yangtze University were collected. The method of labor induction was oral mifepristone + amniotic cavity injection of Ethacridine Lactate. Based on whether or not patients received epidural analgesia, which were divided into EA group (30 cases) and non-EA (NEA) group (30 cases). The primary outcome were visual analog scale (VAS) score of pain and result of follow-up, the secondary outcomes included relative clinical parameter and labor duration. RESULTS: Vaginal induction of labor was successful in both groups. There was no statistically significant difference in VAS of pain between the two groups before analgesia (P > .05), but the VAS of pain in the EA group was significantly lower than the NEA group (P < .05) after analgesia or at delivery. The following outcomes showed no statistical difference between two groups: labor duration, postpartum hemorrhage, hemorrhage ≥ 500 mL, intrapartum injury, second days hemoglobin, C-reactive protein, antibiotic therapy days, hospitalizations days, and placenta residue (P > .05). The median hospitalization costs of EA group was 4697.5 yuan, and NEA group was 3673 yuan, the difference was statistically significant (P < .001). No adverse events related to EA occurred during hospitalization, only 3 patients showed mild lumbago and back pain after follow-up to three months postpartum, which was significantly relieved after proper rest. CONCLUSION: EA can significantly reduce the pain of parturients, which may be effective and safe in the second-trimester induced labor.
|
Authors | Yong Zeng, Tao Jiang, Ya-Hong Zheng, Wen-Rong He, Xiao-Wen Wang, Hua Wei, Li Wang, Zu-Rong Liu, Xu-Feng Zhang, Cunjian Yi, Ke-Ming Chen |
Journal | Medicine
(Medicine (Baltimore))
Vol. 101
Issue 38
Pg. e30767
(Sep 23 2022)
ISSN: 1536-5964 [Electronic] United States |
PMID | 36197253
(Publication Type: Controlled Clinical Trial, Journal Article)
|
Copyright | Copyright © 2022 the Author(s). Published by Wolters Kluwer Health, Inc. |
Chemical References |
- Analgesics
- Anti-Bacterial Agents
- Mifepristone
- C-Reactive Protein
- Ethacridine
|
Topics |
- Analgesia, Epidural
(adverse effects, methods)
- Analgesia, Obstetrical
(adverse effects, methods)
- Analgesics
(pharmacology)
- Anti-Bacterial Agents
(pharmacology)
- C-Reactive Protein
- Ethacridine
(pharmacology)
- Female
- Humans
- Labor, Induced
- Labor, Obstetric
- Mifepristone
- Pain
(etiology)
- Pregnancy
- Pregnancy Trimester, Second
- Prospective Studies
|